Protein Kinase Compound Library

Protein Kinase Compound Library
Artikelnummer
MEXHY-L196-50
Verpackungseinheit
50 µl
Hersteller
MedChemExpress

Verfügbarkeit: wird geladen...
Preis wird geladen...
Description: Protein Kinases (PTKs) are a class of phosphotransferases that phosphorylate proteins. Protein kinases participate in many signal transduction pathways including those involved with growth, differentiation, and cell division. Protein kinase not only plays an important role in the process of cell activation, but also its abnormal expression is closely related to the pathogenesis of many diseases. So far, the protein kinase family has become one of the most important drug targets. The most common drug targets include ALK, B-Raf, BCR-Abl, EGFR, and VEGFR.
Protein Kinases (PTKs) are a class of phosphotransferases that phosphorylate proteins. Protein kinases participate in many signal transduction pathways including those involved with growth, differentiation, and cell division. Protein kinase not only plays an important role in the process of cell activation, but also its abnormal expression is closely related to the pathogenesis of many diseases. So far, the protein kinase family has become one of the most important drug targets. The most common drug targets include ALK, B-Raf, BCR-Abl, EGFR, and VEGFR.
MCE designs a unique collection of 2,827 bioactive compounds targeting protein kinases, which is an important tool for the development of drug targeting protein kinases.
For pre-dissolved solutions, 10 mM for compounds with the solubility not lower than 10 mM, 2 mM for compounds with solubility between 2 mM and 10 mM, and 3 mg/mL for compounds with unconfirmed molecular weight and solubility not lower than 3 mg/mL.

Advantages:
  • A unique collection of 2,827 bioactive compounds targeting protein kinases for high throughput screening (HTS) and high content screening (HCS).
  • The compound library targets include ALK, B-Raf, Bcr-Abl, CaMK etc.
  • Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.
  • Structurally diverse, bioactive, and cell permeable.
  • More detailed compound information with structure, IC50, and other chemical & biological data.
  • High purity and quality validated by NMR and LC/MS.
  • All compounds are in stock and continuously updated.


Formulation: A collection of 2,827 bioactive compounds targeting protein kinases supplied as pre-dissolved Solutions or Solid.Solution:2,758 compounds supplied in 10 mM solution,60 compounds supplied in 2 mM solution,9 compounds supplied in 3 mg/mL solution.

Layout: 96-well storage tube or 96-well plate: 1st and 12th column are left empty.384-well plate: the first two columns and the last two columns are left empty.Compounds with different concentrations or dissolved in different solvents will be put on separate plates.This way of layout may increase the number of plates because there could be three solvents and three concentrations. If you have other requirements, please let us know.

Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Mehr Informationen
Artikelnummer MEXHY-L196-50
Hersteller MedChemExpress
Hersteller Artikelnummer HY-L196-50
Verpackungseinheit 50 µl
Mengeneinheit STK
Produktinformation (PDF)
×
MSDS (PDF)
×